2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Signet Ring Cell Carcinoma in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Q | 1 |
| Karouji, Y | 1 |
| Kobayashi, M | 1 |
| Ihara, S | 1 |
| Konishi, H | 1 |
| Fukui, Y | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma.
Topics: Adenocarcinoma; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Signet Ring Cell; Cell Comm | 2003 |